Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Curanex Pharmaceuticals Inc (CURX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Curanex Pharmaceuticals Inc (CURX), most recent 12 months reported: net loss $10.47M. Latest balance sheet on file: liquid cash $2.94M. From SEC filings. Others in Pharmaceutical Preparations: Corvus Pharmaceuticals, Inc. · Contineum Therapeutics, Inc. · Citius Oncology, Inc. · Citius Pharmaceuticals, Inc. · Cadrenal Therapeutics, Inc. · CYTODYN INC. · CYPHERPUNK TECHNOLOGIES INC. · Decoy Therapeutics Inc.

Stock screener

Watchlist